CSIMarket
 
Insys Therapeutics, Inc.  (INSY)
 

Insys Therapeutics's Suppliers Performance

INSY's Supply Chain




 
INSY Costs vs Sales of Suppliers Growth Insys Therapeutics recorded an increase in cost of sales by 107.58 % year on year, sequentially cost of sales grew by 74.35 % in Q1.

More on INSY Suppliers



Insys Therapeutics recorded increase in cost of sales by 107.58 % year on year, sequentially cost of sales grew by 74.35 % in Q1.

More on INSY Suppliers




Insys Therapeutics's Comment on Supply Chain









INSY's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Insys Therapeutics, Inc. 21.67 65.80 -227.98 -
SUBTOTAL 0.00 0.00 0.00 -


Sources: Insys Therapeutics, Inc.'s official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Insys Therapeutics, Inc.’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.